Friess Associates’s ICU Medical ICUI Stock Holding History

Friess Associates’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-18,400	Closed	-$5.2M	–	129
2018 Q3	$5.2M	Buy	+18,400	New	+$5.39M	0.36%	67

Other funds holding ICUI

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Friess Associates's ICUI Position: Q4 2018 in Review

Friess Associates sold out of ICU Medical (ICUI) in Q4 2018, closing a stake of 18,400 shares — an estimated $5.2M sold.

Friess Associates first reported a position in ICUI in Q3 2018 and held it in 1 quarter. The position peaked at $5.2M in Q3 2018. 294 funds tracked by Wall St. Rank hold ICUI as of Q4 2018.

Friess Associates reported no remaining ICU Medical position as of Q4 2018 after selling out during the quarter.
Friess Associates sold 18,400 ICU Medical shares in Q4 2018, an estimated $5.2M.
Friess Associates first reported a position in ICU Medical in Q3 2018 and held it in 1 quarter.
Friess Associates's ICU Medical position peaked at $5.2M in Q3 2018.
294 funds tracked by Wall St. Rank held ICU Medical as of Q4 2018.

Based on Friess Associates's 13F filing for Q4 2018, filed 14 Feb 2019.